The risk far outweighs any benefit of COVID vaccines. They cause excess mortality around 6 weeks post injection in all age groups.

Accurate estimates of COVID vaccine-induced severe adverse event and death rates are critical
for risk-benefit ratio analyses of vaccination and boosters against SARS-CoV-2 coronavirus in
different age groups. However, existing surveillance studies are not designed to reliably estimate
life-threatening event or vaccine-induced fatality rates (VFR). Here, regional variation in
vaccination rates was used to predict all-cause mortality and non-COVID deaths in subsequent
time periods using two independent, publicly available datasets from the US and Europe (monthand
week-level resolutions, respectively). Vaccination correlated negatively with mortality 6-20
weeks post-injection, while vaccination predicted all-cause mortality 0-5 weeks post-injection in
almost all age groups and with an age-related temporal pattern consistent with the US vaccine
rollout. Results from fitted regression slopes (p<0.05 FDR corrected) suggest a US national average VFR of 0.04% and higher VFR with age (VFR=0.004% in ages 0-17 increasing to 0.06% in ages >75 years), and 146K to 187K vaccine-associated US deaths between February and
August, 2021. Notably, adult vaccination increased ulterior mortality of unvaccinated young (<18,
US; <15, Europe). Comparing our estimate with the CDC-reported VFR (0.002%) suggests
VAERS deaths are underreported by a factor of 20, consistent with known VAERS underascertainment
bias. Comparing our age-stratified VFRs with published age-stratified coronavirus
infection fatality rates (IFR) suggests the risks of COVID vaccines and boosters outweigh the
benefits in children, young adults, and older adults with low occupational risk or previous
coronavirus exposure. Our findings raise important questions about current COVID mass
vaccination strategies and warrant further investigation and review.


Posted in PDF

Leave a Reply